FDA Inspection 1224007 — Bergen Community Regional Blood Center
The FDA completed an inspection of Bergen Community Regional Blood Center on November 21, 2023 in Lincoln Park, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 21, 2023
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Lincoln Park, NJ (United States)